Articles in Press: Clinical Genitourinary Cancer

Property	Value
Status
Version
Ad File
Disable Ads Flag
Environment
Moat Init
Moat Ready
Contextual Ready
Contextual URL
Contextual Initial Segments
Contextual Used Segments
AdUnit
SubAdUnit
Custom Targeting
Ad Events
Invalid Ad Sizes

March 30, 2023

Evaluating real-world characteristics of patients with advanced urothelial carcinoma eligible for avelumab maintenance therapy: a multi-country retrospective medical chart review

Joaquim Bellmunt,
Jane Chang,
Melissa Pavilack-Kirker,
...
Abigail Hitchens,
Sean D. Candrilli,
Mayank Ajmera

Published online: March 30, 2023

March 29, 2023

Toward precision medicine: Development and validation of a machine learning based decision support system for optimal sequencing in castration-resistant prostate cancer

Hakyung Lim,
Jeong Woo Yoo,
Kwang Suk Lee,
...
Abdulghafour Halawani,
Jae-Hyeon Ahn,
Kyo Chul Koo

Published online: March 29, 2023

March 23, 2023

Impact of Concomitant Prostate Cancer Medications on Efficacy and Safety of Relugolix vs Leuprolide in Men with Advanced Prostate Cancer

Daniel J. George,
Fred Saad,
Michael S. Cookson,
...
David Buckley,
Bertrand Tombal,
Neal D. Shore

Published online: March 23, 2023

Expression of RSUME is associated with poor prognosis in clear cell Renal Carcinoma: involvement of ROS related metabolism

David Gonilski-Pacin,
Nicolas Ciancio del Giudice,
Belen Elguero,
Eduardo Arzt

Published online: March 23, 2023

March 22, 2023

Single-dose post-office fulguration mitomycin C instillation appears to improve recurrence-free survival in patients with low-grade non-invasive bladder cancer

Daniel Halstuch,
Paz Lotan,
Idan Karchever,
...
Daniel Kedar,
Jack Baniel,
Shay Golan

Published online: March 22, 2023

March 20, 2023

Variations in penile cancer management: Results from the Global Society of Rare Genitourinary Tumors Survey

Gagan Prakash,
Amandeep Arora,
Marco Bandini,
...
Viraj Master,
Curtis A Pettaway,
Philippe E Spiess

Published online: March 20, 2023

March 18, 2023

Clinico-pathological features influencing the prognostic role of Body Mass Index in patients with advanced Renal Cell Carcinoma treated by immuno-oncology combinations (ARON-1)

Matteo Santoni,
Francesco Massari,
Zin W. Myint,
...
Nicola Battelli,
Mimma Rizzo,
Camillo Porta

Published online: March 18, 2023

March 17, 2023

Identifying the Needs of Health Care Providers in Advanced First-Line Renal Cell Carcinoma: A Mixed-Methods Research

Patrice Lazure,
Matthew T. Campbell,
Monica Augustyniak,
...
Emily A. Lemke,
Eric P. Cohen,
Ginny Jacobs

Published online: March 17, 2023

Open Access

March 16, 2023

Sequential treatment with Bacillus Calmette-Güerin (BCG) and mitomycin C administered with Electromotive Drug Administration (EMDA) in patients with high-risk non-muscle invasive bladder cancer after BCG failure

Isabel Sanz Gómez,
Jorge Huguet,
Alejandra Bravo,
...
Josep María Gaya,
Joan Palou,
Alberto Breda

Published online: March 16, 2023

Urinary Neuroendocrine Neoplasms Treated in the “Modern Era”: A Multicenter Retrospective Review

Bryan Khuong Le,
Patrick McGarrah,
Alan Paciorek,
...
Tiffany Le,
Emily Bergsland,
Thorvardur R. Halfdanarson

Published online: March 16, 2023

Open Access

March 9, 2023

The short- and long-term effect of radical cystectomy in frail patients with bladder cancer

Nikolaos Pyrgidis,
Ioannis Sokolakis,
Gena Haltmair,
Georgios Hatzichristodoulou

Published online: March 09, 2023

Pseudoprogression and Mixed Responses in Metastatic Renal Cell Carcinoma Patients Treated With Nivolumab: A Retrospective Analysis

Lorenz Haaker,
Marcella Baldewijns,
Liesbeth De Wever,
...
Wim Wynendaele,
Gert De Meerleer,
Benoit Beuselinck

Published online: March 09, 2023

February 27, 2023

Phase 1 Study of Safety and Preliminary Clinical Activity of JNJ-63898081, a PSMA and CD3 Bispecific Antibody, for Metastatic Castration-Resistant Prostate Cancer

Emerson A. Lim,
Michael T. Schweizer,
Kim N. Chi,
...
Nibedita Bandyopadhyay,
Hong Xie,
Aaron R. Hansen

Published online: February 27, 2023

February 24, 2023

Differential Prognostic Value of Extrarenal Involvement in Patients With Non-Metastatic Renal Cell Cancer

Giacomo Musso,
Giuseppe Fallara,
Giuseppe Rosiello,
...
Andrea Salonia,
Francesco Montorsi,
Umberto Capitanio

Published online: February 24, 2023

February 21, 2023

Added Clinical Value of 18F-FDG-PET/CT to Stage Patients With High-Risk Non-Muscle Invasive Bladder Cancer Before Radical Cystectomy

Added Clinical Value of ¹⁸F-FDG-PET/CT to Stage Patients With High-Risk Non-Muscle Invasive Bladder Cancer Before Radical Cystectomy

Noor van Ginkel,
Erik J. van Gennep,
Liselot Oosterbaan,
...
Theo M. de Reijke,
Bas W.G. van Rhijn,
Laura S. Mertens

Published online: February 21, 2023

February 16, 2023

Taxanes Versus Androgen Receptor Therapy as Second-Line Treatment for Castrate-Resistant Metastatic Prostate Cancer After First-Line Androgen Receptor Therapy

Antonin Broyelle,
Nicolas Delanoy,
André-Michel Bimbai,
...
Arnauld Villers,
Loïc Lebellec,
Stéphane Oudard

Published online: February 16, 2023

Radical Prostatectomy Technique Dispute: Analyzing Over 1.35 Million Surgeries in 20 Years of History

Tomás B.C. Moretti,
Luís A. Magna,
Leonardo O. Reis

Published online: February 16, 2023

February 15, 2023

Dose Intensity in Real-World Patients With Metastatic Renal Cell Carcinoma Taking Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitors

Hartlee Johnston,
Allison M. Deal,
Katherine P. Morgan,
Bianka Patel,
Matthew I. Milowsky,
Tracy L. Rose

Published online: February 15, 2023

February 14, 2023

Global Trends of Prostate Cancer by Age, and Their Associations With Gross Domestic Product (GDP), Human Development Index (HDI), Smoking, and Alcohol Drinking

Junjie Huang,
Erica On-Ting Chan,
Xianjing Liu,
...
Chi-Fai Ng,
Jeremy Yuen-Chun Teoh,
Martin C.S. Wong

Published online: February 14, 2023

February 9, 2023

Baseline and Dynamic Changes in Hemoglobin Levels Predict Treatment Response and Prognosis in Metastatic Renal Cell Carcinoma: A Multicenter Retrospective Study

Yu-Hsuen Yang,
Sonam Ansel,
Aafke Meerveld-Eggink,
...
Thomas Powles,
Balaji Venugopal,
Bernadett Szabados

Published online: February 09, 2023

Open Access

February 8, 2023

Estimated Direct Costs of Renal Cancer by Stage of Disease at Diagnosis and Phase of Its Management: A Whole-Disease Model

Alessandra Buja,
Giuseppe De Luca,
Maura Gatti,
...
Umberto Basso,
Vittorina Zagonel
For IRENE Investigators

Published online: February 08, 2023

February 1, 2023

Life-threatening hemoptysis in patients with kidney cancer chest metastases

Viral M. Patel,
Roy Elias,
Annapoorani Asokan,
...
Raquibul Hannan,
Robert Timmerman,
James Brugarolas

Published online: February 01, 2023

January 26, 2023

Practice Patterns Regarding Female Reproductive Organ-Sparing and Nerve-Sparing Radical Cystectomy Among Urologic Oncologists in the United States

Natasha Gupta,
Lauren Kucirka,
Alice Semerjian,
Phillip M. Pierorazio,
Stacy Loeb,
Trinity J. Bivalacqua

Published online: January 26, 2023

January 25, 2023

Predictive and Prognostic Role of the Neutrophil-to-Lymphocyte Ratio in Muscle Invasive Bladder Cancer Treated With Neoadjuvant Chemotherapy and Radical Cystectomy

Markus von Deimling,
Victor M. Schuettfort,
David D'Andrea,
...
Margit Fisch,
Michael Rink,
Shahrokh F. Shariat

Published online: January 25, 2023

Sarcopenia in Men With Bone-Predominant Metastatic Castration-Resistant Prostate Cancer Undergoing Ra-223 Therapy

Maira Khan,
Shruti Parshad,
Mahdi F. Naimi,
...
Cameron M. Phillips,
Juan Briones,
Urban Emmenegger

Published online: January 25, 2023

Survival and Economic Impact of Rapid Prostate-Specific Antigen Doubling Time in Patients With Nonmetastatic Castration-Resistant Prostate Cancer

Stephen J. Freedland,
Krishnan Ramaswamy,
Ahong Huang,
...
Neil M. Schultz,
Nora Janjan,
Daniel J. George

Published online: January 25, 2023

Open Access

January 19, 2023

The role of immune checkpoint inhibitors (ICI) as adjuvant treatment in renal cell carcinoma (RCC): A systematic review and meta-analysis

Fernando Sabino Marques Monteiro,
Andrey Soares,
Alessandro Rizzo,
...
Veronica Mollica,
Enrique Grande,
Francesco Massari

Published online: January 19, 2023

January 17, 2023

Local treatment Associated With Prognosis among Men With Metastatic Prostate Cancer: A SEER-Based Study

Jiatong Zhou,
Yiqun Cao,
Haojie Chen,
Yanyuan Wu,
Jie Ding,
Jun Qi

Published online: January 17, 2023

January 3, 2023

Effect of Bisphosphonates on Skeletal Related Events in Long Bone Metastases of Renal Cell Carcinoma: A Systematic Review

Danique LM van Broekhoven,
Lisa W Dootjes,
Astrid van der Veldt,
Carola Zillikens,
Jakob van Oldenrijk

Published online: January 03, 2023

Open Access

December 30, 2022

Role of Race and Insurance Status in Prostate Cancer Diagnosis-to-Treatment Interval

Daniel R. Nemirovsky,
Charles Klose,
Michael Wynne,
...
Benjamin Taber,
Shawn Haji-Momenian,
Michael J. Whalen

Published online: December 30, 2022

December 25, 2022

Association of Androgen Deprivation Therapy with Metabolic Disease in Prostate Cancer Patients: An Updated Meta-Analysis

Justin Swaby,
Ankita Aggarwal,
Akshee Batra,
...
Neeraj Agarwal,
Martha Terris,
Avirup Guha

Published online: December 25, 2022

December 21, 2022

The Importance of Repeat Imaging Prior to Treatment Decision-making in Testicular Cancer: Commentary From the Inaugural Global Society of Rare Genitourinary Tumors Summit

Kristen McAlpine,
Roderick Clark,
Philippe E. Spiess,
Andrea Necchi,
Kenneth Gage,
Robert J. Hamilton

Published online: December 21, 2022

December 19, 2022

Five-Year Outcome and Safety in Patients Treated With Immune Checkpoint Blockade Therapies for Urothelial Carcinoma: Experience From Real-World Clinical Practice

Deniz Tural,
Cagatay Arslan,
Fatih Selcukbiricik,
...
Dilek Erdem,
Nuri Karadurmus,
Saadettin Kilickap

Published online: December 19, 2022

December 6, 2022

Age-Related Differences in Oncological Outcomes in Renal Cell Carcinoma: Impact of Functional Conservation as Measured by Postoperative eGFR

Julia H. Yuan,
Hajime Tanaka,
Dattatraya Patil,
...
Yasuhisa Fujii,
Viraj Master,
Ithaar H. Derweesh

Published online: December 06, 2022

Log Odds of Positive Lymph Nodes (LODDS) as an Independent Predictor of Overall Survival Following Radical Cystectomy in Urothelial Bladder Cancer: Time to Rethink Conventional Node Staging

Abolfazl Salari,
Mohammadreza Ghahari,
Ali Nowroozi,
...
Seyed Ali Momeni,
Mohammad Reza Nowroozi,
Erfan Amini

Published online: December 06, 2022

December 5, 2022

The Changing Face of cN0M0 Prostate Cancer Being Found With pN+ After Surgery in the Contemporary Era: Results of an International European Survey on Disease Management

Matteo Sacco,
Giorgio Gandaglia,
Kirsti Aas,
...
Paolo Gontero,
Giancarlo Marra
on behalf of The YAU Prostate Cancer Working Group

Published online: December 05, 2022

December 2, 2022

Long-term Clinical Outcomes of a Spanish Cohort of Metastatic Renal Cell Carcinoma Patients with a Complete Response to Sunitinib

Guillermo de Velasco,
Teresa Alonso-Gordoa,
Alejo Rodríguez-Vida,
...
Javier Afonso,
Susana Hernando Polo,
Úrsula Asensio

Published online: December 02, 2022

November 24, 2022

Development and Internal Validation of a Nomogram Predicting Overall Survival Based on Log ODDS of Positive Lymph-Nodes for Post Radical Cystectomy Patients in Muscle Invasive Carcinoma of Bladder

Keval N Patel,
Abhijeet Salunke,
Mohit Sharma,
...
Vikas Warikoo,
Ganesh Bakshi,
Shashank J Pandya

Published online: November 24, 2022

First-Line Lenvatinib Plus Pembrolizumab or Everolimus versus Sunitinib for Advanced Renal Cell Carcinoma: A United States-Based Cost-Effectiveness Analysis

Youwen Zhu,
Kun Liu,
Dong Ding,
Libo Peng

Published online: November 24, 2022

Open Access

November 19, 2022

Systemic Immune-inflammation Index (SII) During Induction has Higher Predictive Value Than Preoperative SII in Non-muscle-invasive Bladder Cancer Patients Receiving Intravesical Bacillus Calmette -Guerin

Li Deng-xiong,
Yu Qing-xin,
Feng De-chao,
...
Wu Rui-cheng,
Xu Shi,
Ping Han

Published online: November 19, 2022

Open Access

November 18, 2022

Prognostic Model for Clear-cell Renal Cell Carcinoma Based on Natural Killer Cell-related Genes.

Xuezhong Shi,
Mengyang Yuan,
Yongli Yang,
...
Ani Dong,
Huili Zhu,
Xiaocan Jia

Published online: November 18, 2022

November 17, 2022

Predictors of Pelvic Lymph Nodal Metastasis in Penile Squamous Cell Carcinoma- Results From a Matched-Pair Analysis

Akash P. Sali,
Ashish Shah,
Gagan Prakash,
...
Archi Aggarwal,
Sangeeta B. Desai,
Santosh Menon

Published online: November 17, 2022

Exploring Texture Analysis to Optimize Bladder Preservation in Muscle Invasive Bladder Cancer

Prachi Mehta,
Shwetabh Sinha,
Sheetal Kashid,
Debanjan Chakraborty,
Ritesh Mhatre,
Vedang Murthy

Published online: November 17, 2022

Incidence of Benign Renal Masses in a Contemporary Cohort of Patients Receiving Partial Nephrectomy for Presumed Renal Cell Carcinoma

Varun Vijay,
Fjolla Hyseni Vokshi,
Michael Smigelski,
Shavy Nagpal,
William C. Huang

Published online: November 17, 2022

November 13, 2022

The Changing Landscape of Systemic Therapy in the Treatment of Synchronous Metastatic Hormone-sensitive Prostate Cancer

Edward Lambert,
Nicolaas Lumen,
Valerie Fonteyne,
...
Geert Villeirs,
Kathia De Man,
Charles Van Praet

Published online: November 13, 2022

November 12, 2022

A Systematic Review and Meta-Analysis of Clinicopathologic Factors Predicting Upper Urinary Tract Recurrence After Radical Cystectomy for Urothelial Bladder Cancer

Mehdi Kardoust Parizi,
Vitaly Margulis,
Yair Lotan,
Abdulmajeed Aydh,
Shahrokh F. Shariat

Published online: November 12, 2022

November 11, 2022

Multicenter Database of Patients with Germ-Cell Tumors: A Latin American Cooperative Oncology Group Registry (LACOG 0515)

Diogo A. Bastos,
Aline Bobato Lara Gongora,
Carlos Dzik,
...
Fabio A. Schutz,
Oren Smaletz,
Andre P. Fay

Published online: November 11, 2022

Open Access

November 10, 2022

Oligometastatic Hormone-Sensitive Prostate Cancer. Why Radiotherapy?

Marta Barrado Los Arcos,
Fernando López-Campos,
Marta López Valcarcel,
...
Vérane Achard,
Shankar Siva,
Felipe Couñago

Published online: November 10, 2022

September 14, 2022

Multi-Institution Evaluation of Sequential Intravesical Gemcitabine and Docetaxel in the Treatment of Bacillus Calmette-Guerin Naïve Patients with Non-Muscle Invasive Bladder Cancer

Lewis J. Thomas,
Ryan L. Steinberg,
Vignesh T. Packiam,
...
Sarah L. Mott,
Kenneth G. Nepple,
Michael A. O'Donnell

Published online: September 14, 2022

July 29, 2016

WITHDRAWN: A Unique Case of Perivascular Epithelioid Cell Tumor Associated With Birt-Hogg-Dube Syndrome

Parikshit Padhi,
Parth Rali,
Yousef Hattab,
Opoku Adjapong,
Khalid J. Malik,
Shifeng Mao

Published online: July 29, 2016